← All trials
NCT02071095
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2014
- Primary completion
- Apr 1, 2017
- Completion date
- Apr 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 15
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Icahn School of Medicine at Mount SinaiLead sponsor
- Rockefeller UniversityOverall official - principal investigator
- Oncovir, Inc.Collaborator
- National Institute of Allergy and Infectious Diseases (NIAID)Collaborator
- The Campbell FoundationCollaborator
- National Institutes of Health (NIH)Collaborator
- Icahn School of Medicine at Mount SinaiSponsor investigator
- Icahn School of Medicine at Mount SinaiStudy director
- Icahn School of Medicine at Mount SinaiOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.